Gyre Therapeutics Updates Corporate Address and Contact Info
Ticker: GYRE · Form: 8-K · Filed: May 22, 2025 · CIK: 1124105
| Field | Detail |
|---|---|
| Company | Gyre Therapeutics, Inc. (GYRE) |
| Form Type | 8-K |
| Filed Date | May 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-update, address-change
TL;DR
Gyre Therapeutics moved offices, new address is 12770 High Bluff Dr, Ste 150, San Diego, CA 92130.
AI Summary
On May 22, 2025, Gyre Therapeutics, Inc. (formerly Catalyst Biosciences, Inc.) filed an 8-K report. The filing indicates a change in the company's principal executive offices to 12770 High Bluff Drive, Suite 150, San Diego, CA 92130. The company's telephone number has also been updated to (858) 567-7770.
Why It Matters
This filing provides updated contact and location information for Gyre Therapeutics, Inc., which is crucial for investors and stakeholders to ensure they are using the correct details for communication and official correspondence.
Risk Assessment
Risk Level: low — The filing is a routine update of corporate information and does not contain any material financial or operational changes that would inherently increase risk.
Key Players & Entities
- Gyre Therapeutics, Inc. (company) — Registrant
- May 22, 2025 (date) — Report Date
- 12770 High Bluff Drive, Suite 150, San Diego, CA 92130 (address) — New Principal Executive Offices
- (858) 567-7770 (phone_number) — Updated Telephone Number
- Catalyst Biosciences, Inc. (company) — Former Company Name
- Targacept Inc (company) — Former Company Name
FAQ
What is the new principal executive office address for Gyre Therapeutics, Inc.?
The new principal executive office address is 12770 High Bluff Drive, Suite 150, San Diego, CA 92130.
What is the updated telephone number for Gyre Therapeutics, Inc.?
The updated telephone number for Gyre Therapeutics, Inc. is (858) 567-7770.
What was Gyre Therapeutics, Inc. formerly known as?
Gyre Therapeutics, Inc. was formerly known as Catalyst Biosciences, Inc. and prior to that, Targacept Inc.
On what date was this 8-K report filed?
This 8-K report was filed on May 22, 2025.
What is the state of incorporation for Gyre Therapeutics, Inc.?
Gyre Therapeutics, Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding GYRE THERAPEUTICS, INC. (GYRE).